- €90.27m
- €136.54m
- €29.57m
Annual balance sheet for H2APEX SCA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | ARS | Interim Report | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 10.8 | 117 | 0.149 | 34.8 | 2.59 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.056 | 0.52 | 16.8 | 17 | 21.2 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 57.1 | 122 | 23.5 | 61.7 | 37.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.059 | 0.026 | 33.5 | 53.3 | 50.6 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 57.2 | 122 | 61.7 | 122 | 91.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 16.6 | 4.3 | 18.2 | 30 | 26.7 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 16.6 | 4.31 | 69.8 | 64.7 | 61.1 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 40.6 | 118 | -8.02 | 57.7 | 30.1 |
| Total Liabilities & Shareholders' Equity | 57.2 | 122 | 61.7 | 122 | 91.2 |
| Total Common Shares Outstanding |